Bruker Corporation. (5/28/19). "Press Release: Bruker Corporation to Present at Jefferies 2019 Global Healthcare Conference". Billerica, MA.

	Region	New York, NY
	Country	United States (USA)
	Organisation	Bruker Corporation (Nasdaq: BRKR)
	Group	Bruker (Group)
	Organisation 2	Jefferies Group Inc.
	Today	Jefferies LLC
	Group	Leucadia (Group)
	Product	Jefferies 2019 Global Healthcare Conference New York
	Product 2	analytical instrument
	Index term	Bruker–Leucadia: investor conference, 201906 supply service Bruker presents at Jefferies Healthcare Conference in New York
	Person	Laukien, Frank H. (Bruker 201204 President + CEO)
	Person 2	Srega, Jürgen (Bruker 201302– President Bruker CALID Group before BRAHMS + Thermo Fisher Bremen)

Bruker Corporation (Nasdaq: BRKR) announced today that it will participate in a fireside chat at the Jefferies 2019 Global Healthcare Conference in New York on Thursday, June 6, 2019 at 4:00 pm EDT. Presenting for the company will be Frank Laukien, President and Chief Executive Officer, and Juergen Srega, President, Bruker CALID Group.

A live audio webcast of the event will be available on the Investor Relations section of the Company's Web site at https://ir.bruker.com. A replay of the presentation will be posted on the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation.

About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: www.bruker.com.

Contact :
Pam Clark
Investor Relations
Bruker Corporation
T: +1 (978) 663 – 3660, ext.1479
E: investor.relations@bruker.com

Record changed: 2023-06-05